Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 55,917 |
|
|||||
| News | - | ||||||
| Day High | 1.03 | Low High |
|||||
| Day Low | 0.99 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| IN8bio Inc | INAB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.04 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.03 | 0.99 | 1.03 | 1.04 | 1.04 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 172 | 55,917 | US$ 1.01 | US$ 56,338 | - | 0.65 - 3.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 328 | US$ 1.04 | USD |
IN8bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 43.29M | 43.29M | - | 0 | -30.01M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
IN8bio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INAB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.02 | 1.09 | 0.94 | 1.03 | 200,852 | 0.02 | 1.96% |
| 1 Month | 1.17 | 1.2199 | 0.9164 | 1.09 | 700,922 | -0.13 | -11.11% |
| 3 Months | 1.28 | 1.45 | 0.9164 | 1.12 | 342,469 | -0.24 | -18.75% |
| 6 Months | 0.91 | 2.48 | 0.65 | 1.39 | 487,092 | 0.13 | 14.29% |
| 1 Year | 2.00 | 3.48 | 0.65 | 1.68 | 497,460 | -0.96 | -48.00% |
| 3 Years | 10.00 | 10.319 | 0.65 | 2.54 | 597,871 | -8.96 | -89.60% |
| 5 Years | 10.00 | 10.319 | 0.65 | 2.54 | 597,871 | -8.96 | -89.60% |
IN8bio Description
| IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. |
